Background: Colorectal cancer (CRC) remains a major global health challenge, with limited immunotherapy efficacy in microsatellite stable (MSS) tumors that comprise ~85% of cases. The p53 tumor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback